Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/1998
06/10/1998CN1183989A Buffering liquid for staphylococcus Aureus Injection and stephylococcus Aureus Injection with buffering liquid
06/10/1998CN1183960A Controlled release pharmaceutical compositions for oral administration containing nifedipine as active substance
06/10/1998CN1183957A Medical liposome ointment
06/09/1998US5763598 Branched cyclodextrins and method for producing them
06/09/1998US5763584 Receptor activation with hepatocyte growth factor agonists
06/09/1998US5763582 Derivatives of triterpenoid acids and uses thereof
06/09/1998US5763504 Photcurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof
06/09/1998US5763493 Stabilized pharmaceutical
06/09/1998US5763476 Sublingual or buccal pharmaceutical composition
06/09/1998US5763449 Aqueous medium containing polyvinylpyrrolidone, c3-c6 polyol, ammonium glycyrrhizinate, flavors
06/09/1998US5763435 Administering to mammal to treat liver disease or inflammatory condition of gastrointestinal tract
06/09/1998US5763425 Gastrointestinal toxicity side effect inhibition
06/09/1998US5763424 Sequestering agent
06/09/1998US5763416 Stimulating bone repair and regeneration
06/09/1998US5763409 Stable freeze-dried formulation comprising a protein assay kit
06/09/1998US5763405 Stabilized composition for oral administration of peptides
06/09/1998US5763401 Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
06/09/1998US5763395 Stable bactericidal mixtures for use in mouth washes or cosmetics
06/09/1998US5763394 Human growth hormone aqueous formulation
06/09/1998US5763268 Hepatitis delta virus compositions and expression vectors
06/09/1998US5763172 Incubating a solution of targeted intracellular rna with a metallotexaphyrin-oligonucleotide conjugate having catalytic activity and complementary binding affinity to the target
06/09/1998US5762992 Method of preventing a decrease in sweetness of thaumatin
06/09/1998US5762958 Multilipid component ether lipid liposomes
06/09/1998US5762956 Multilayer drug delivery system with backings with estrogen and progestin hormones, adhesives and permeation enhancing agents
06/09/1998US5762955 Method for application and maintenance of medication on body tissue
06/09/1998US5762951 Analgesics, antacids
06/09/1998US5762950 Delivery of medicines, proteins, hormones
06/09/1998US5762927 Exposing primate to immunotoxin, administering lymph node lymphocytes, transplanting organ
06/09/1998US5762923 Stabilized interferon alpha solutions
06/09/1998US5762918 Angiogenesis
06/09/1998US5762916 Cosmetic and/or pharmaceutical preparations
06/09/1998US5762909 Combining active material with carrier, introducing into blood vessel
06/09/1998US5762907 Frozen radiopharmaceutical formulations
06/09/1998US5762906 Further improvements relating to radiolabelling of proteins
06/09/1998CA2157142C Treatment of diseases caused by sebaceous gland disorders
06/09/1998CA2120133C Crystalline amifostine compositions and methods for the preparation and use of same
06/04/1998WO1998023753A1 Systems for determining substances active against hpv-associated diseases
06/04/1998WO1998023735A1 Immune responses using compositions containing stress proteins
06/04/1998WO1998023604A1 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
06/04/1998WO1998023306A1 Process for preparing polymer coatings grafted with polyethylene oxide chains containing covalently bonded bio-active agents
06/04/1998WO1998023292A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
06/04/1998WO1998023291A1 Percutaneous delivery system
06/04/1998WO1998023289A1 MODULATION OF IgG BINDING TO FcRn
06/04/1998WO1998023286A2 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy
06/04/1998WO1998023277A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents
06/04/1998WO1998023275A1 Use of mixtures of active substances for the production of hypocholesteremic agents
06/04/1998WO1998023270A1 Pharmaceutical formulation
06/04/1998WO1998023262A2 Lozenge for the modified releasing of active substances in the gastrointestinal tract
06/04/1998WO1998017325A3 Covalent polar lipid conjugates for targeting
06/04/1998WO1998016255A3 Stabilized conjugates of uncomplexed subunits of multimeric proteins
06/04/1998WO1998011919A3 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
06/04/1998WO1998010762A3 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride
06/04/1998WO1998004294A3 Radiolabeled annexins
06/04/1998WO1998000171A3 Conjugates of thrombin inhibitors and endogenes carriers
06/04/1998DE19648576A1 Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt Lozenge modified release of active substances in the gastrointestinal tract
06/04/1998DE19646759A1 Mittel zur Desinfektion der Haut und Schleimhaut Means for disinfecting the skin and mucous membranes
06/04/1998CA2273341A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic preparations
06/04/1998CA2273206A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients
06/04/1998CA2273097A1 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
06/04/1998CA2272754A1 Use of mixtures of active substances for the production of hypocholesterolemic agents
06/04/1998CA2272536A1 Immune responses using compositions containing stress proteins
06/03/1998EP0845503A2 Liquid carotenoid compound preparations miscible with oil
06/03/1998EP0845476A2 Synthetic catalytic oligonucleotides
06/03/1998EP0845265A1 Mucosal preparation containing physiologically active peptide
06/03/1998EP0845259A2 Stable sunscreening compositions containing surface active glucose derivatives and water soluble UV-filters
06/03/1998EP0845255A1 Aquous dispersion of vesicles resistant to dehydration
06/03/1998EP0844891A1 Hyper comb-branched polymer conjugates
06/03/1998EP0844886A2 Bioconjugates of manganese complexes and their application as catalysts
06/03/1998EP0844885A2 Chemical compounds
06/03/1998EP0844868A1 Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
06/03/1998EP0614527A4 Gel particle contrast media for improved diagnostic imaging.
06/03/1998CN1183727A Method of preventing TPO adsorption and stable TPO-contg. composition
06/03/1998CN1183724A Laryngeal bactericidal and antiseptic composition
06/03/1998CN1183723A Transdermal therapeutic system for administering testosterone
06/03/1998CN1183721A Pharmaceutical composition contg. tiagabine hydrochloride and process for its preparation
06/03/1998CN1183302A Eye drops contg. sodium hyaluronate and preparing method thereof
06/02/1998US5760200 Nucleophile, activator
06/02/1998US5760184 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
06/02/1998US5760152 Crosslinked isocyanate functional polymer supports
06/02/1998US5760096 Potent penetration enhancers
06/02/1998US5760094 Masks taste of medicines or nutritional supplements
06/02/1998US5760072 Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
06/02/1998US5760022 Pharmaceutical composition with improved bioavailability of inositol phosphate
06/02/1998US5760017 Cyclodextrin derivatives usable in particular for solubilizing hydrophobic chemical compounds such as medicaments and their preparation process
06/02/1998US5760016 Use of mono-3,6-anhydrocyclodextrins for solubilizing a hydrophobic compound and for controlling the purity of an enantiomer and process for the preparation of these cyclodextrins
06/02/1998US5760015 Cyclodextrin compounds and methods of making and use thereof
06/02/1998US5759997 Carrier mixture of ethoxylated, hydrogenated castor oil andglycerides
06/02/1998US5759766 Skin disorders with allogenic cells
06/02/1998US5759583 Polylactic/glycolic acid copolymer, bioactive agent and quaternary ammonium surfactant
06/02/1998US5759580 Hypotensive agents
06/02/1998US5759579 Pharmaceutical suspension systems
06/02/1998US5759577 Controlled release of steroids from sugar coatings
06/02/1998US5759576 Controlled release of steroids from sugar coatings
06/02/1998US5759573 Extending half-life of drugs
06/02/1998US5759572 Liposome with oligosaccharide on surface
06/02/1998US5759565 Galenic compositions comprising calcitonin and their use
06/02/1998US5759563 Liquid delivery compositions
06/02/1998US5759548 Using plant extract
06/02/1998US5759546 Treatment of CD4 T-cell mediated conditions
06/02/1998US5759532 Controlled release of miotic and myriatic drugs in the anterior chamber
1 ... 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 ... 1712